Some evidence suggests that, at least in ezrin, Thr235 is phosphorylated by cyclin-dependent kinase 5 (CDK5) and cooperates with Thr576 for its full activation and the cell morphology changes induced in osteosarcoma cells during senescence [62]. The gene discussed is CDK5; the disease is osteosarcoma.